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KISS1 Gene Polymorphisms in Korean Girls with Central 
Precocious Puberty
Kisspeptin/G-protein couple receptor-54 (GPR54) system plays a key role in the activation 
of the gonadotropic axis at puberty. Central precocious puberty (CPP) is caused by the 
premature activation of hypothalamic gonadotropin-releasing hormone secretion. This 
study was aimed to identify KISS1 gene variations and to investigate the associations 
between KISS 1 gene variations and CPP in Korean girls. All coding exons of KISS1 gene 
were sequenced in Korean girls with CPP (n = 143) and their healthy controls (n = 101). 
Nine polymorphisms were identified in KISS1 gene. A novel single-nucleotide 
polymorphism (SNP), 55648176 T/G, was identified for the first time. SNP 55648184 C/G 
and 55648186 -/T were detected more frequently in CPP group than in control group. SNP 
55648176 T/G was detected less frequently in CPP group than in control group. Haplotype 
GGGC-ACCC was detected less frequently in CPP group. The genetic variations of KISS1 
gene can be contributing factors of development of CPP. The association between the 
gene variations and CPP should be validated by further evidence obtained from large-
scaled and functional studies. 
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INTRODUCTION
Puberty is a complex and coordinated biologic process of sexual 
development that leads to complete gonadal maturation and 
function, and attainment of reproductive capacity. Puberty can 
be influenced by genetic, nutritional, environmental, and socio-
economic factors (1). The activation of pulsatile gonadotropin-
releasing hormone (GnRH) secretion from specialized hypotha-
lamic neurons to stimulate hormonal cascades and gonadal ac-
tivation is a key event in the onset of puberty (2). However, the 
ultimate mechanisms underlying the increase in pulsatile GnRH 
secretion at puberty have yet to be fully elucidated (3). 
 Kisspeptin, the peptide product of KISS1 gene, and its puta-
tive receptor, G protein-54 (GPR54) signaling complex, have re-
cently emerged as an essential gatekeeper of pubertal activation 
of GnRH neurons and the reproductive axis (4-8). An increase 
in kisspeptin signaling, which is caused by enhanced expres-
sion of KISS1 and GPR54 genes at the time of puberty, contrib-
utes to, or even drives, activation of the gonadotropic axis dur-
ing pubertal development (9). Kisspeptin is a powerful stimulus 
for GnRH-induced gonadotropin secretion, and intermittent 
kisspeptin administration to immature animals was shown to 
induce precocious activation of the gonadotropic axis and pu-
bertal development (10). In our previous study (11), we dem-
onstrated that serum kisspeptin levels were significantly higher 
in girls with Central precocious puberty (CPP) than in their age-
matched pre-pubertal controls (4.61 ± 1.78 vs. 2.15 ± 1.52 pM/
L, P < 0.001), consistent with the first report on kisspeptin serum 
levels in pre-pubertal girls and in girls with CPP in 2009 (12). 
 Precocious puberty is defined as the development of second-
ary sexual characteristics before the age of 8 yr for girls and 9 yr 
for boys (13). CPP is diagnosed if the process is driven by pre-
mature activation of hypothalamic GnRH secretion. As CPP may 
cause early epiphyseal maturation with compromised final hei-
ght as well as psychological stress, early initiation of treatment 
is important to improve final height (14). CPP has remarkable 
female gender predominance and most of CPP cases are idio-
pathic (1, 13). However, genetic factors are known to play a fun-
damental role in the timing of pubertal onset (15, 16). Segrega-
tion analysis has suggested autosomal dominant transmission 
with incomplete, sex-dependent penetrance (15). Recently, an 
activating mutation of GPR54 gene was identified in a girl with 
CPP, implicating the kisspeptin system in the pathogenesis of 
sexual precocity (17). Because of the important function of kiss-
peptin in the regulation of puberty onset, alterations in KISS1 
gene might contribute to the pathogenesis of CPP, as could al-
terations in GPR54 gene. Thus far, few studies, especially in Ko-
rean populations have described mutations or polymorphisms 
of KISS1 gene (18-20). 
 KISS1 gene was first discovered in 1996. This gene consists of 
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three exons, and only parts of the second and third exons are 
ultimately translated into the 145-amino acid precursor peptide 
(21). This precursor is then cleaved into three forms of kisspep-
tins containing 54, 14, or 13 amino acids. The three peptides ex-
hibit the same affinity for their single receptor since they share 
a common C-terminal decapeptide, designated kisspeptin-10 
(5, 6). 
 In this study, we aimed to identify the sequence variations, 
including mutations and single-nucleotide polymorphisms 
(SNPs) of KISS1 gene. We also attempted to investigate the as-
sociations between KISS 1 gene variations and CPP in Korean 
girls.
MATERIALS AND METHODS
Subjects
Two groups of subjects were involved in this study. Korean girls 
with CPP (n = 143) were recruited from Korea University Ansan 
Hospital in Gyeonggi-do, Korea. CPP was diagnosed in accor-
dance with the following criteria: 1) objective breast budding 
appearing before the age of 8 yr, 2) advanced bone age at least 1 
yr ahead of the chronological age, and 3) significantly higher 
peak luteinizing hormone (LH) values compared with the cut-
off value of 5 IU/L according to a GnRH stimulation test con-
ducted prior to the age of 9 yr. CPP patients with identified eti-
ology, such as a brain tumor or cranial irradiation, were exclud-
ed. The pubertal stage of each participant was determined by a 
pediatric endocrinologist and rated according to the Tanner 
criteria. Bone age, expressed in years, was determined by a sin-
gle observer according to Greulich and Pyle method. 
 The control group (n = 101) consisted of healthy Korean girls 
who showed breast development after the age of 9 yr. They were 
recruited as volunteers. The mean age of control group was 10.03 
± 0.68 yr. The mean height and weight standard deviation scores 
(SDSs) were 0.66 ± 1.16 and 1.12 ± 1.65, respectively. 
KISS1 gene analysis
Genomic DNA was isolated from the peripheral blood leuko-
cytes of the study subjects using a DNA isolation kit (QIAamp 
DNA Blood Maxi prep kit; Qiagen, Valencia, CA, USA). All cod-
ing exons (exons 2 and 3) and intronic flanking regions of KISS1 
gene were PCR amplified with four pairs of specific primers (Ta-
ble 1). Amplification was conducted over 35 cycles, and each 
cycle consisted of denaturation at 95°C for 30 sec (exon 2) or 50 
sec (exon 3), annealing at 50°C (exon 2) or 63°C (exon 3) for 30 
sec (exon 2) or 50 sec (exon 3), and extension at 72°C for 30 sec 
(exon 2) or 50 sec (exon 3). An additional extension was perform-
ed at 72°C for 10 min after the last amplification cycle. PCR was 
performed in a reaction volume of 20 μL containing 100 ng of 
genomic DNA template, 1 μM of each primer, 10 mM of each 
dNTP, 25 mM MgCl2, 100 mM KCl, 20 mM Tris-HCl (pH 8.3), 
and 1 U of Taq DNA polymerase (Takara Bio Inc., Shiga, Japan). 
After amplification, PCR mixtures were separated on 1.5% aga-
rose gels with ethidium bromide to confirm the size and purity 
of the PCR products. Subsequently, DNA sequencing reactions 
were conducted using the same primer pairs and a BigDye Ter-
minator V3.1 Cycle Sequencing kit (Applied Biosystems, Foster 
City, CA, USA) in accordance with the manufacturer’s instruc-
tions. The sequencing reaction mixtures were electrophoresed 
and analyzed using an ABI3130xl Genetic Analyzer (Applied 
Biosystems) and Sequencing Analysis v.5.2 software.
GnRH stimulation test
The GnRH stimulation test was conducted to evaluate the pu-
bertal status in all patients. Basal serum samples were obtained 
prior to GnRH (Relefact® LH-RH 0.1 mg; Aventis Pharma, Frank-
furt, Germany) injection, and post-stimulation samples were 
acquired 30, 60, and 90 min after injection to measure LH and 
FSH (follicle-stimulating hormone) levels. The hormonal levels 
were measured using chemiluminescent microparticle immu-
noassays (Abbott Laboratories, Abbott Park, IL, USA).
Haplotype construction and statistical analysis
Haplotypes were estimated from genotype data for individual 
participants using the PHASE program, version 2.0. Deviations 
from Hardy-Weinberg equilibrium were assessed by compari-
son of observed and expected genotype frequencies with a per-
mutation test. The IBM SPSS 20.0 Network version program 
was used to perform statistical analyses. Data are expressed as 
the mean ± standard deviation (SD). Fisher’s exact test and the 
independent t- test were used for data analysis, and P values <  
0.05 were considered statistically significant. The odds ratios for 
SNPs were also calculated with respective 95% confidence in-
tervals. 
Ethics statement
This study was approved by the institutional review board of 
Korea University Ansan Hospital, Ansan, Korea (IRB number 
AS10036). Written informed consents were obtained from the 
parents of all subjects.
RESULTS
Clinical characteristics and the results of GnRH 
stimulation test in CPP patients
In patient group, the mean age was 8.30 ± 0.81 yr. The mean 
bone age was 10.28 ± 1.12 yr, and the mean discrepancy from 
Table 1. Primers used in the analysis of KISS1 gene
Primer Forward (5´ to 3´) Reverse (3´ to 5´)
Exon 2 CTCTACCAGGAGCCTCCAAAG TGATCTTTCCTGTTTACCAGCC
Exon 3 ATGGGATGACAGGAGGTGTTG ACCATCCATTGAGGATGGAAG
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the chronological age was 1.84 ± 1.48 yr. The mean height and 
weight SDSs were 1.11 ± 0.96 and 1.33 ± 1.30, respectively. Ac-
cording to the results of the GnRH stimulation test, the mean 
basal LH levels were 0.43 ± 0.73 IU/L, and the mean peak LH 
levels were 12.24 ± 10.50 IU/L. The basal FSH levels were 2.63 
± 1.11 IU/L, and the mean peak FSH levels were 13.77 ± 3.91 
IU/L. The peak LH/FSH ratio was 0.93 ± 0.71. The baseline clin-
ical characteristics and the results of GnRH stimulation tests in 
the patient group are summarized in Table 2.
Polymorphisms identified in KISS1 gene analysis
Direct sequencing of KISS1 gene revealed nine SNPs (Table 3). 
Among the nine polymorphisms detected in this study, 55648176 
T/G was a novel polymorphism whereas the other eight have 
been previously reported. 55648343 C/A was previously identi-
fied in Chinese CPP patients in 2007 (19) and in Korean CPP 
patients in 2010 (18) and was shown to be a nonsynonymous 
change, leading to a substitution of P110T. Additionally, there 
was another nonsynonymous SNP (55648429 C/G) found that 
leads to the substitution of P81R. 55648386 C/T was initially iden-
tified in Korean CPP patients in 2010 (18), and was found to be 
synonymous. The novel SNP in this study (55648196 T/G) is lo-
cated in an untranslated region. SNPs 55648184 C/G, 55648180 
G/A and 55648186 -/T are also located in untranslated regions.
Comparison of allele and genotype frequencies between 
CPP and control groups
Allele and genotype counts and frequencies in CPP and control 
groups are shown in Table 4. The associations between the poly-
morphisms and the two phenotypes were evaluated using Fish-
er’s exact test. No polymorphisms showed different genotype 
frequencies between CPP and control groups. The 55648184 C/
G, 55648176 T/G, and 55648186 -/T polymorphisms showed 
different allele frequencies between CPP and control groups, 
but no significant differences in the frequencies of the other six 
polymorphisms were noted between the two groups. 
 The 55648184 C/G polymorphism was detected more fre-
quently in CPP group than in control group (P = 0.017). Using 
the C allele as the reference, the odds ratio of the G allele for 
CPP was 1.567 (95% CI, 1.091-2.252). The 55648186 -/T poly-
morphism was also detected more frequently in CPP group 
than in control group (P = 0.044). Using the - allele as the refer-
ence, the odds ratio of the Ins T allele for CPP was 1.458 (95% 
CI, 1.015-2.095). The 55648176 T/G polymorphism was detect-
ed less frequently in CPP group than in control group (P = 0.030). 
Using the T allele as the reference, the odds ratio of the G allele 
for CPP was 0.339 (95% CI, 0.125-0.920).
Comparison of clinical characteristics and the results of 
GnRH stimulation test between the carriers and non-
carriers of gene variations in CPP subjects
Clinical characteristics and the results of GnRH stimulation test 
including age, height and weight SDSs, bone age, bone age ad-
vancement, basal LH and FSH levels, peak LH and FSH levels, 
and peak LH/FSH ratio were compared between the carriers 
and non-carriers of SNPs 55648184 C/G, 55648176 T/G and 
55648186 -/T in CPP subjects. No parameters showed signifi-
cant differences between two subgroups in CPP subjects.
Comparison of haplotype frequencies between CPP and 
control groups
In total, 21 haplotypes were constructed based on the typing 
Table 2. Clinical characteristics and the results of GnRH stimulation test in patient 
group
Parameters Patients (n = 143)
Age (yr) 8.30 ± 0.81
Height (SDS) 1.11 ± 0.96
Weight (SDS) 1.33 ± 1.30
BMI (kg/m2) 18.29 ± 2.50
BA (yr) 10.28 ± 1.12
BA-CA (yr) 1.84 ± 1.48
Basal LH (IU/L) 0.43 ± 0.73
Peak LH (IU/L) 12.24 ± 10.50
Basal FSH (IU/L) 2.63 ± 1.11
Peak FSH (IU/L) 13.77 ± 3.91
Peak LH/FSH ratio 0.93 ± 0.71
Data are shown as the mean ± standard deviation. BA, bone age; CA, chronological 
age; BA-CA, bone advancement; SDS, standard deviation score; BMI, body mass in-
dex; LH, luteinizing hormone; FSH, follicle-stimulating hormone.
Table 3. KISS1 gene polymorphisms identified by sequencing
No. Position* Allele Location dbSNP ID Frequency in sample Note
1 55648429 C/G Exon 3 rs4889 0.545/0.455 p.P81R
2 55648254 A/- Exon 3 rs71745629 0.553/0.447 p.X139fx
3 55648386 C/T Exon 3 - 0.988/0.012 Synonymous
4 55648343 C/A Exon 3 - 0.941/0.059 p.P110T
5 55648184 C/G Exon 3 rs1132506 0.494/0.506 Untranslated
6 55648181 G/C/A Exon 3 rs1132514 0.969/0.031 Untranslated
7 55648176 T/G Exon 3 - 0.963/0.037 Novel, Untranslated
8 55648180 G/A Exon 3 rs112442813 0.969/0.031 Untranslated
9 55648186 -/T Exon 3 rs35128240 0.514/0.486 Untranslated
*The positions of polymorphisms are defined according to contig NT_004487.19.
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results and their relationships with CPP were also investigated 
(Table 5). Haplotype GGGC-ACCC was detected less frequently 
in the CPP group than in the control group (P = 0.024). The odds 
ratio of haplotype GGGC-ACCC for CPP was 0.309 (95% CI, 0.106-
0.903). None of the other haplotypes differed in frequency be-
tween the two groups.
DISCUSSION
In 2003, kisspeptin was initially demonstrated to function in the 
reproductive axis, wherein mutations in GPR54 gene result in 
idiopathic hypogonadotropic hypogonadism (4, 7). These mu-
tations suggested that kisspeptin and its receptor, GPR54, are 
the crucial regulators of puberty and the hypothalamus-pitu-
itary-gonadal axis. Since 2003, further mutations have been 
identified in GPR54 gene and were demonstrated to cause idio-
pathic hypogonadotropic hypogonadism (8, 22, 23). Further-
more, an activating mutation was shown to lead to CPP (17). 
However, no definite causative mutation has been detected in 
another promising candidate gene, KISS1, in humans with id-
iopathic hypogonadotropic hypogonadism or CPP. 
 In this study, nine SNPs were detected through sequencing 
of KISS1 gene, and the frequencies of each SNP were calculated 
and compared between CPP and control groups. Although they 
were detected in both groups, the frequencies of SNPs 55648184 
C/G and 55648186 -/T, and a novel SNP, 55648176 T/G, were 
found to differ significantly between the CPP and control groups. 
SNPs 55648184 C/G and 55648186 -/T were detected more fre-
quently in the CPP group, and SNP 55648176 T/G was detected 
less frequently in the CPP group compared to the control group. 
 All of these SNPs are found in the untranslated region of the 
gene and they are all located in close proximity to each other. 
Untranslated regions can contain elements for controlling gene 
expression and it is assumed that these SNPs are located within 
the regulatory sequences that affect the transcription of the rest 
of the DNA. Changes in the DNA sequence as a result of these 
polymorphisms could alter the function of the regulatory se-
quences, subsequently altering the production of kisspeptin.
Table 4. Allele and genotype frequencies of KISS1 polymorphisms 
Polymorphism Group
Allele counts (frequency) Genotype counts (frequency)
P value*
1 2 11 12 22
55648429 C/G C = 1, G = 2 CPP
Control
146
120
0.510
0.594
140
82
0.490
0.406
36
39
0.252
0.386
74
42
0.517
0.416
33
20
0.231
0.198
0.079
55648254 A/- A = 1, Del A = 2 CPP
Control
150
120
0.524
0.594
136
82
0.476
0.406
36
39
0.252
0.386
78
42
0.545
0.416
29
20
0.203
0.198
0.140
55648386 C/T C = 1, T = 2 CPP
Control
282
200
0.986
0.990
4
2
0.014
0.010
139
99
0.972
0.980
4
2
0.028
0.020
0
0
0.000
0.000
0.999
55648343 C/A C = 1, A = 2 CPP
Control
266
193
0.930
0.955
20
9
0.070
0.045
123
92
0.860
0.911
20
9
0.140
0.089
0
0
0.000
0.000
0.331
55648184 C/G C = 1, G = 2 CPP
Control
128
113
0.448
0.559
158
89
0.552
0.441
28
35
0.196
0.347
72
43
0.503
0.426
43
23
0.301
0.228
0.017
55648181 G/C/A G = 1, C or A = 2 CPP
Control
277
196
0.969
0.970
9
6
0.031
0.030
134
95
0.937
0.941
9
6
0.063
0.059
0
0
0.000
0.000
0.999
55648176 T/G T = 1, G = 2 CPP
Control
280
190
0.979
0.941
6
12
0.021
0.059
137
89
0.958
0.881
6
12
0.042
0.119
0
0
0.000
0.000
0.030
55648180 G/A G = 1, A = 2 CPP
Control
277
196
0.969
0.970
9
6
0.031
0.030
134
95
0.937
0.941
9
6
0.063
0.059
0
0
0.000
0.000
0.999
55648186 -/T Wild = 1, Ins T = 2 CPP
Control
136
115
0.476
0.569
150
87
0.524
0.431
36
39
0.252
0.386
64
37
0.448
0.366
43
25
0.301
0.248
0.044
*Comparison between the allele frequencies of patient and control groups.
Table 5. Haplotype analysis
Haplotype*
CPP Control
P value
Count Frequency Count Frequency
TGGGT-CCG 132 0.462 76 0.376 0.061
TGGC-ACCC 103 0.360 87 0.431 0.115
TGGC-AACC 14 0.049 8 0.040 0.665
GGGC-ACCC 5 0.018 11 0.055 0.024
TACG-ACCC 7 0.025 6 0.030 0.724
TGGG-ACCC 4 0.014 1 0.005 0.409
TGGCTACCC 2 0.007 3 0.015 0.653
TGGGT-CTG 3 0.011 2 0.010 0.999
TGGGTACCG 4 0.014 1 0.005 0.409
TGGGTACCC 3 0.011 1 0.005 0.646
TGGCTAACC 2 0.007 1 0.005 0.999
TGGCT-CCG 0 0.000 2 0.010 0.171
TGGGTAACC 2 0.007 0 0.000 0.514
TGGGT-CCC 0 0.000 1 0.005 0.414
TACG--CCC 1 0.004 0 0.000 0.999
GGGC--CCC 0 0.000 1 0.005 0.414
TGGCTAACG 1 0.004 0 0.000 0.999
TGGG-ACCG 0 0.000 1 0.005 0.414
TGGGTAATC 1 0.004 0 0.000 0.999
TACC-ACCC 1 0.004 0 0.000 0.999
GGGG-ACCC 1 0.004 0 0.000 0.999
*The haplotypes are designated according to the sequence of each SNP position as 
follows: 55648176 T/G, 55648180 G/A, 55648181 G/C/A, 55648184 C/G, 55648186 
-/T, 55648254 A/-, 55648343 C/A, 55648386 C/T, 55648429 C/G.
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 SNP 55648343 C/A was first reported in a study of Chinese 
CPP patients in 2007 (19), which demonstrated that p.P110T 
was an infrequent polymorphism with an allele frequency of 
0.057 in all sequenced subjects. This allele frequency was quite 
similar to that in the Korean population assessed in 2010, in which 
the frequency for this allele was 0.046 (18). Moreover, p.P110T 
was found to be significantly more frequent in controls than in 
CPP patients in two separate studies (18, 19). It has been sug-
gested that p.P110T may exert a protective effect on pubertal 
precocity (18, 19). However, these findings have yet to be con-
firmed by functional studies, thus more evidence is required. In 
the present study, the allele frequency for this polymorphism 
was 0.059, similar to that in the previous studies, but no signifi-
cant differences in the frequencies between the two study groups 
were detected (P = 0.331). Therefore this SNP seems not to have 
a critical effect on the activity of kisspeptins.
 The nonsynonymous SNP 55648429 C/G was not found to be 
statistically associated with CPP (P = 0.079). Previous associa-
tion studies in Korean and Chinese populations also found no 
relationship between this SNP and CPP (18, 19). This polymor-
phism introduced a substitution of proline for arginine at the 
81st, a substitution that was observed in kisspeptin-54, but not 
in the other three forms of kisspeptin (kisspeptin-14, -13, and 
-10). Therefore, the amino acid change caused by SNP 55648429 
C/G would not be expected to seriously influence the bioactivi-
ty of kisspeptins. This supposition was supported by the results 
of a previous study showing that kisspeptin-54 was unstable 
and could readily degrade into kisspeptin-14, -13, and -10 (5). 
Thus, kisspeptin-14, -13, and -10 might be more biologically 
important than kisspeptin-54.
 SNP 55648254 A/- leads to a frameshift mutation from the 
139th site of KISS1 protein. But, there were no significant differ-
ences in the allele frequencies of this polymorphism between 
the CPP and control groups (P = 0.140). Considering the fact 
that the 139th amino acid is not included in the three natural in 
vivo forms of kisspeptin, kisspeptin-54, -14, and -13, this frame-
shift mutation seems not to alter the function of kisspeptins. 
 A comparison of haplotypes with CPP revealed that haplotype 
GGGC-ACCC was detected less frequently in CPP patients than 
in controls (P = 0.024). These findings suggest that haplotype 
GGGC-ACCC exerts a protective effect against CPP. Haplotype 
GGGC-ACCC is a combination of the G allele of SNP 55648176 
T/G, the C allele of SNP 55648184 C/G, the wild-type allele of 
SNP 55648186 -/T, and the wild-type alleles of the other SNPs. 
According to the genotyping results, the G allele of SNP 55648176 
T/G, C allele of SNP 55648184 C/G, and the wild-type allele of 
SNP 55648186 -/T were detected less frequently in the CPP group 
than in the control groups. Therefore, the results of the haplo-
type analysis suggest that the SNPs with significance do not have 
an effect on CPP separately, but work in combination with one 
another. As mentioned above, SNPs 55648176 T/G, 55648184 
C/G, and 55648186 -/T are located in the untranslated region 
and they are in close proximity to each other. Untranslated re-
gions can contain regulatory sequences for controlling gene ex-
pression. Accordingly, it is assumed that the SNPs identified in 
this study work together to affect the transcription of the rest of 
the DNA. 
 In a previous Chinese study (19), eight SNPs were detected in 
KISS1 gene, and only two SNPs (55648429 C/G and 55648343 
C/A) identified were in common with those found in this Kore-
an study. However, six SNPs detected in exon 3 in the current 
study were consistent with those identified in the previous Ko-
rean study (18). In particular, SNP 55648386 C/T, identified in 
the current study, was novel. The genetic background of these 
two ethnic groups appear to differ profoundly, even though Ko-
reans and Chinese are both ethnically Asians. 
 A possible limitation of the present study was that the sample 
size was relatively small and P values of 0.017, 0.030, and 0.044 
were not sufficiently significant. The association between gene 
variations and CPP could not be validated with further support 
from functional data. Therefore, the association should be vali-
dated by further evidence obtained from large-scaled and func-
tional studies. 
 In brief, this study was aimed to identify the sequence varia-
tions and haplotypes of KISS1 gene associated with CPP in Ko-
rean girls. A novel SNP, 55648176 T/G, was identified for the 
first time. The allele frequencies of three SNPs, 55648184 C/G, 
55648186 -/T, and 55648176 T/G, were found to differ signifi-
cantly between CPP and control groups. The haplotype GGGC-
ACCC was identified as one that can exert a protective effect 
against CPP. The genetic variations of KISS1 gene can be con-
tributing factors of development of CPP.
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